Toggle navigation
Home
Search
Services
Blog
Contact
About
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott
Neorx Corporation, Seattle, WA, United States
Search 444 grants from D Wilbur
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target
Ass, NOS2, and Alcoholic Liver Disease
Glial cell behavior in the developing visual system
Cholesterol &protein-lipid effects on Ach Receptor
Role of BRCA1 as A Human Prostate Suppressor Gene
Recently added grants:
Adducin, actin cytoskeleton and cognitive impairments
Microbiota-Brain Axis in Alzheimer's Disease: MIND Diet-Induced Effects
Neuroimaging and Molecular Markers of AD and Neurodegenerative Disease after Concussion
Detrusor Underactivity as an HCN-mediated Failure of Resilience in Aging
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067941-001
Application #
3614582
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
NIH 1986
N43 CM
Astatine-211 Labeled Antibodies for Therapy
Wilbur, D Scott / Neorx Corporation
Comments
Be the first to comment on this grant